Saga Diagnostics AB

https://www.sagadiagnostics.com

SAGA Diagnostics is a personalized cancer genomics and disease monitoring company that offers molecular genetic testing of tissue biopsies and non-invasive “liquid biopsies” such as blood samples. SAGA helps pharmaceutical companies, scientists, and biomedical laboratory providers to detect actionable mutations, stratify patient groups, and monitor treatment response more accurately and to an industry-leading lower limit of detection of 0.001%. Analysis of circulating tumor DNA using these proprietary technologies gives SAGA unique ultrasensitivity, ultimately giving patients peace of mind. *

	Start	2017-09-13 existent
	Predecessor	University of Lund (Lund University)
	Industry	BIOTECH
	Person	Saal, Lao (Saga Diagnostics 201906 CEO)
	Person 2	Nilsson, Åke (Saga Diagnostics 201803– Director Corporate + Business Development)

	Region	Lund
	Country	Sweden
	Street	2 Scheelevägen Medicon Village
	City	22381 Lund
	Tel	+46-70-888-5261
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Saga Diagnostics AB. (6/11/19). "Press Release: Saga Raises 40 Million SEK (€3.7 Million) to Advance Ultrasensitive Cancer Liquid Biopsies". Lund & Oslo.

		Record changed: 2024-02-12